Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 318


A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer.

Houédé N, Pulido M, Mourey L, Joly F, Ferrero JM, Bellera C, Priou F, Lalet C, Laroche-Clary A, Raffin MC, Ichas F, Puech A, Piazza PV.

Oncologist. 2014 Dec;19(12):1227-8. doi: 10.1634/theoncologist.2014-0345. Epub 2014 Oct 29.


Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.

Tsatsaris V, Capitant C, Schmitz T, Chazallon C, Bulifon S, Riethmuller D, Picone O, Poulain P, Lewin F, Lainé F, Jacqz-Aigrain E, Aboulker JP, Launay O; Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group.

Ann Intern Med. 2011 Dec 6;155(11):733-41. doi: 10.7326/0003-4819-155-11-201112060-00005.


Basal plasma leptin levels in healthy elderly males are related to physical fitness without impact on bone metabolism.

Maïmoun L, Simar D, Caillaud C, Coste O, Puech AM, Jaussent A, Mariano-Goulart D, Sultan C.

J Sports Med Phys Fitness. 2011 Mar;51(1):160-8.


[Homage to Professor Pierre Simon].

Puech A.

Therapie. 2009 Sep-Oct;64(5):353. doi: 10.2515/therapie/2009058. Epub 2009 Oct 30. French. No abstract available.


How to anticipate the assessment of the public health benefit of new medicines?

Massol J, Puech A, Boissel JP; Participants inRound Table No 7, Giens XXII.

Therapie. 2007 Sep-Oct;62(5):427-35. doi: 10.2515/therapie:2007071. Epub 2008 Jan 19.


[How should one anticipate the assessment of the public health benefit of new medicines?].

Massol J, Puech A, Boissel JP; Participants à la table ronde no 7 de Giens XXII.

Therapie. 2007 Sep-Oct;62(5):417-25. doi: 10.2515/therapie:2007072. Epub 2008 Jan 19. French. No abstract available.


[State of unmet medical needs in France in 2006: necessity of reinforcing research effort].

Jouan-Flahault C, Billon N, Castaigne A, Henry YD, Omnes C, Puech A, Rosilio M, Lassale C.

Therapie. 2007 Sep-Oct;62(5):393-415. doi: 10.2515/therapie:2007069. Epub 2008 Jan 19. French.


No negative impact of reduced leptin secretion on bone metabolism in male decathletes.

Maïmoun L, Coste O, Puech AM, Peruchon E, Jaussent A, Paris F, Rossi M, Sultan C, Mariano-Goulart D.

Eur J Appl Physiol. 2008 Feb;102(3):343-51. Epub 2007 Oct 18.


KIT is required for hepatic function during mouse post-natal development.

Magnol L, Chevallier MC, Nalesso V, Retif S, Fuchs H, Klempt M, Pereira P, Riottot M, Andrzejewski S, Doan BT, Panthier JJ, Puech A, Beloeil JC, de Angelis MH, Hérault Y.

BMC Dev Biol. 2007 Jul 5;7:81.


Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome.

Long JM, LaPorte P, Merscher S, Funke B, Saint-Jore B, Puech A, Kucherlapati R, Morrow BE, Skoultchi AI, Wynshaw-Boris A.

Neurogenetics. 2006 Nov;7(4):247-57. Epub 2006 Aug 10.


Variation in IL-1beta gene expression is a major determinant of genetic differences in arthritis aggressivity in mice.

Ohmura K, Johnsen A, Ortiz-Lopez A, Desany P, Roy M, Besse W, Rogus J, Bogue M, Puech A, Lathrop M, Mathis D, Benoist C.

Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12489-94. Epub 2005 Aug 19.


Training and aging modulate the loss-of-balance phenotype observed in a new ENU-induced allele of Otopetrin1.

Besson V, Nalesso V, Herpin A, Bizot JC, Messaddeq N, Romand R, Puech A, Blanquet V, Hérault Y.

Biol Cell. 2005 Oct;97(10):787-98.


In silico genetics: identification of a functional element regulating H2-Ealpha gene expression.

Liao G, Wang J, Guo J, Allard J, Cheng J, Ng A, Shafer S, Puech A, McPherson JD, Foernzler D, Peltz G, Usuka J.

Science. 2004 Oct 22;306(5696):690-5.


Circulating leptin concentrations can be used as a surrogate marker of fat mass in acute spinal cord injury patients.

Maïmoun L, Puech AM, Manetta J, Badiou S, Paris F, Ohanna F, Rossi M, Sultan C.

Metabolism. 2004 Aug;53(8):989-94.


Genetics of dark skin in mice.

Fitch KR, McGowan KA, van Raamsdonk CD, Fuchs H, Lee D, Puech A, Hérault Y, Threadgill DW, Hrabé de Angelis M, Barsh GS.

Genes Dev. 2003 Jan 15;17(2):214-28.


Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.

Müller MJ, Wetzel H, Eich FX, Rein W, Puech A, Benkert O; Amisulpride Study Group.

J Clin Psychopharmacol. 2002 Dec;22(6):554-60.


Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.

Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, Aurich-Costa J, Cherif D, Gimalac A, Van Duijn C, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13675-80. Epub 2002 Oct 3. Erratum in: Proc Natl Acad Sci U S A 2002 Dec 24;99(26):17221. Ouelette, G [corrected to Ouellette, G]; Realson, J [corrected to Raelson, J].


Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.

Peuskens J, Möller HJ, Puech A.

Eur Neuropsychopharmacol. 2002 Aug;12(4):305-10.


Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.

Lebrun-Vignes B, Archer VC, Diquet B, Levron JC, Chosidow O, Puech AJ, Warot D.

Br J Clin Pharmacol. 2001 May;51(5):443-50.


Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor.

Berlin I, de Brettes B, Aymard G, Diquet B, Arnulf I, Puech AJ.

Int J Neuropsychopharmacol. 2000 Mar;3(1):35-43.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk